Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$2.47M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$3.8M$7.7M2025 · bought $0 · sold $7.7M20252026 · bought $0 · sold $223K2026
Total +$0.0000 bought · $7.91M sold

All filings on record

Every Form 4 transaction we track for this filer

CYTKSell
2026-06-01 · CYTOKINETICS INC
$223.2K
CYTKGrant
2026-05-27 · CYTOKINETICS INC
2,851
RNAMReturn
2026-02-27 · Avidity Biosciences, Inc.
6,692
CYTKGrant
2026-01-15 · CYTOKINETICS INC
$12.5K
STOKSell
2025-12-08 · Stoke Therapeutics, Inc.
$44.1K
STOKSell
2025-12-08 · Stoke Therapeutics, Inc.
$269.1K
STOKSell
2025-12-08 · Stoke Therapeutics, Inc.
$120.3K
STOKSell
2025-12-05 · Stoke Therapeutics, Inc.
$15.9K
STOKSell
2025-12-05 · Stoke Therapeutics, Inc.
$52.4K
STOKSell
2025-12-05 · Stoke Therapeutics, Inc.
$199.5K
STOKSell
2025-12-04 · Stoke Therapeutics, Inc.
$38.6K
STOKSell
2025-12-04 · Stoke Therapeutics, Inc.
$160.6K
STOKExercise
2025-12-03 · Stoke Therapeutics, Inc.
26,250
STOKSell
2025-12-03 · Stoke Therapeutics, Inc.
$20.1K
STOKSell
2025-12-03 · Stoke Therapeutics, Inc.
$12.7K
STOKSell
2025-12-02 · Stoke Therapeutics, Inc.
$12.2K
STOKSell
2025-12-02 · Stoke Therapeutics, Inc.
$19.5K
CYTKSell
2025-12-01 · CYTOKINETICS INC
$1.87M
CYTKExercise
2025-12-01 · CYTOKINETICS INC
$285.0K
CYTKExercise
2025-12-01 · CYTOKINETICS INC
$100.0K
CYTKSell
2025-11-11 · CYTOKINETICS INC
$336.8K
CYTKExercise
2025-11-11 · CYTOKINETICS INC
$50.0K
CYTKGrant
2025-10-15 · CYTOKINETICS INC
$12.5K
STOKSell
2025-10-08 · Stoke Therapeutics, Inc.
$750.0K
STOKExercise
2025-10-08 · Stoke Therapeutics, Inc.
$15.0K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.